Comparison of radical treatment and mortality in patients with non-metastatic prostate cancer in England and USA

被引：0
|
作者：
Sachdeva, A. [1 ]
van der Meulen, J. [1 ]
Emberton, M. [1 ]
Cathcart, P. [1 ]
机构：
[1] Royal Coll Surgeons England, London WC2A 3PN, England
来源：
BJU INTERNATIONAL | 2014年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [21] Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA
    Olaoluwa Lediju
    Joshua Ikuemonisan
    Simpa S. Salami
    Oluwakayode Adejoro
    Journal of Racial and Ethnic Health Disparities, 2019, 6 : 401 - 408
  • [22] Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA
    Lediju, Olaoluwa
    Ikuemonisan, Joshua
    Salami, Simpa S.
    Adejoro, Oluwakayode
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2019, 6 (02) : 401 - 408
  • [23] Suicide and accidental deaths among patients with non-metastatic prostate cancer
    Dalela, Deepansh
    Krishna, Nandita
    Okwara, James
    Preston, Mark A.
    Abdollah, Firas
    Choueiri, Toni K.
    Reznor, Gally
    Sammon, Jesse D.
    Schmid, Marianne
    Kibel, Adam S.
    Nguyen, Paul L.
    Menon, Mani
    Trinh, Quoc-Dien
    BJU INTERNATIONAL, 2016, 118 (02) : 286 - 297
  • [24] External validation of a new model for predicting prostate cancer specific mortality in primary non-metastatic prostate cancer
    Teo, J. S.
    Huang, H. H.
    Lophatananon, A.
    Muir, K.
    Gnanapragasam, V.
    Lee, L. S.
    BJU INTERNATIONAL, 2017, 119 : 14 - 14
  • [25] Primary Radical Therapy Selection in High-risk Non-metastatic Prostate Cancer
    Gnanapragasam, V. J.
    Payne, H.
    Syndikus, I.
    Kynaston, H.
    Johnstone, T.
    CLINICAL ONCOLOGY, 2015, 27 (03) : 136 - 144
  • [26] Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer
    Luzzago, Stefano
    Palumbo, Carlotta
    Rosiello, Giuseppe
    Pecoraro, Angela
    Deuker, Marina
    Stolzenbach, Franziska
    Alessandro Mistretta, Francesco
    Tian, Zhe
    Musi, Gennaro
    Montanari, Emanuele
    Shariat, Shahrokh F.
    Saad, Fred
    Briganti, Alberto
    de Cobelli, Ottavio
    Karakiewicz, Pierre, I
    SURGICAL ONCOLOGY-OXFORD, 2021, 37
  • [27] Non-metastatic prostate cancer: rationale for conservative treatment and impact on disease-related morbidity and mortality in the elderly
    Loffeler, Sven
    Halland, Adrian
    Fawad, Haris
    Beisland, Christian
    Haug, Erik S.
    SCANDINAVIAN JOURNAL OF UROLOGY, 2020, 54 (02) : 105 - 109
  • [28] Medical androgen deprivation therapy and increased non-cancer mortality in non-metastatic prostate cancer patients aged ≥66 years
    Abdollah, F.
    Sammon, J. D.
    Reznor, G.
    Sood, A.
    Schmid, M.
    Klett, D. E.
    Sun, M.
    Aizer, A. A.
    Choueiri, T. K.
    Hu, J. C.
    Kim, S. P.
    Kibel, A. S.
    Nguyen, P. L.
    Menon, M.
    Trinh, Q. -D.
    EJSO, 2015, 41 (11): : 1529 - 1539
  • [29] Physician preferences for non-metastatic castration-resistant prostate cancer treatment
    Srinivas, Sandy
    Mohamed, Ateesha F.
    Appukkuttan, Sreevalsa
    Botteman, Marc
    Ng, Xinyi
    Joshi, Namita
    Horodniceanu, Erica
    Waldeck, A. Reginald
    Simmons, Stacey J.
    BMC UROLOGY, 2020, 20 (01)
  • [30] Does frailty influence treatment intent in men with non-metastatic prostate cancer?
    Connors, K.
    Vickers, A.
    Conroy, R.
    Coyle, C.
    Hudson, A.
    Logue, J.
    Serra, M.
    Tran, A.
    Mistry, H.
    Wylie, J.
    Choudhury, A.
    Song, Y. P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1098 - S1098
12345